RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/17145956http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/17145956http://www.w3.org/2000/01/rdf-schema#comment"Colitis involves immune cell-mediated tissue injuries, but the contribution of epithelial cells remains largely unclear. Vanin-1 is an epithelial ectoenzyme with a pantetheinase activity that provides cysteamine/cystamine to tissue. Using the 2,4,6-trinitrobenzene sulfonic acid (TNBS)-colitis model we show here that Vanin-1 deficiency protects from colitis. This protection is reversible by administration of cystamine or bisphenol A diglycidyl ether, a peroxisome proliferator-activated receptor (PPAR)gamma antagonist. We further demonstrate that Vanin-1, by antagonizing PPARgamma, licenses the production of inflammatory mediators by intestinal epithelial cells. We propose that Vanin-1 is an epithelial sensor of stress that exerts a dominant control over innate immune responses in tissue. Thus, the Vanin-1/pantetheinase activity might be a new target for therapeutic intervention in inflammatory bowel disease."xsd:string
http://purl.uniprot.org/citations/17145956http://purl.org/dc/terms/identifier"doi:10.1084/jem.20061640"xsd:string
http://purl.uniprot.org/citations/17145956http://purl.uniprot.org/core/author"Garcia S."xsd:string
http://purl.uniprot.org/citations/17145956http://purl.uniprot.org/core/author"Martin F.M."xsd:string
http://purl.uniprot.org/citations/17145956http://purl.uniprot.org/core/author"Naquet P."xsd:string
http://purl.uniprot.org/citations/17145956http://purl.uniprot.org/core/author"Galland F."xsd:string
http://purl.uniprot.org/citations/17145956http://purl.uniprot.org/core/author"Bagnis C."xsd:string
http://purl.uniprot.org/citations/17145956http://purl.uniprot.org/core/author"Pouyet L."xsd:string
http://purl.uniprot.org/citations/17145956http://purl.uniprot.org/core/author"Millet V."xsd:string
http://purl.uniprot.org/citations/17145956http://purl.uniprot.org/core/author"Berruyer C."xsd:string
http://purl.uniprot.org/citations/17145956http://purl.uniprot.org/core/author"Canonici A."xsd:string
http://purl.uniprot.org/citations/17145956http://purl.uniprot.org/core/author"LeGoffic A."xsd:string
http://purl.uniprot.org/citations/17145956http://purl.uniprot.org/core/date"2006"xsd:gYear
http://purl.uniprot.org/citations/17145956http://purl.uniprot.org/core/name"J Exp Med"xsd:string
http://purl.uniprot.org/citations/17145956http://purl.uniprot.org/core/pages"2817-2827"xsd:string
http://purl.uniprot.org/citations/17145956http://purl.uniprot.org/core/title"Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity."xsd:string
http://purl.uniprot.org/citations/17145956http://purl.uniprot.org/core/volume"203"xsd:string
http://purl.uniprot.org/citations/17145956http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/17145956
http://purl.uniprot.org/citations/17145956http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/17145956
http://purl.uniprot.org/uniprot/P37231#attribution-EA64A063DDC781A0F1843E247266E0C8http://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/17145956
http://purl.uniprot.org/uniprot/O95497#attribution-EA64A063DDC781A0F1843E247266E0C8http://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/17145956
http://purl.uniprot.org/uniprot/#_Q3UEK0-mappedCitation-17145956http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/17145956
http://purl.uniprot.org/uniprot/#_Q9Z0K8-mappedCitation-17145956http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/17145956
http://purl.uniprot.org/uniprot/Q9Z0K8http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/17145956